'Tell women about cancer drug risk'.
Women taking the anti-cancer drug Tamoxifen should he told of the risks so they can make informed choices about its use. a leading breast care nurse said last week. Anne Tate, board member of the RCN's Breast Care Nurses' Group, teas commenting on a Dutch study published in The Lancet that suggests a link between the drug and endometrial cancer. Though the study stresses that for women already being treated for breast cancer the benefits of 'Tamoxifen outweigh its possible side-effects, it claims that healthy women who use it to prevent breast cancer could be at risk. But a pilot study at the Royal Marsden Hospital on Tamoxifen's use in healthy women found minimal side-effects. And the UK Co-ordinating Committee on Cancer Research, now running a new study, says the Dutch research shows the risk is lower than expected.